CORECIVIC, INC. (CXW) capitalization

Current snapshot

Market Cap
$1.87B
98.9M shares × $18.91 · as of last filing 2026-03-31
Net Worth
$1.40B
Stockholders' equity · 2026-03-31
Enterprise Value
$3.07B
Market cap + debt − cash
Net Debt
$1.20B
Debt $1.41B − Cash $209.7M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $2.05B
FY'24 2024-12-31 $2.41B
FY'23 2023-12-31 $1.65B
FY'22 2022-12-31 $1.37B
FY'21 2021-12-31 $1.20B
FY'20 2020-12-31 $792.1M
FY'19 2019-12-31 $2.07B
FY'18 2018-12-31 $2.12B
FY'17 2017-12-31 $2.67B
FY'16 2016-12-31 $2.88B
FY'15 2015-12-31 $3.12B
FY'14 2014-12-31 $4.26B
FY'13 2013-12-31 $3.72B
FY'12 2012-12-31 $3.55B
FY'11 2011-12-31 $2.03B
FY'10 2010-12-31 $2.75B
FY'10 2009-12-31 $2.85B
FY'10 2008-12-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $1.87B
Q4'25 2025-12-31 $1.91B
Q3'25 2025-09-30 $2.17B
Q2'25 2025-06-30 $2.29B
Q1'25 2025-03-31 $2.22B
Q4'24 2024-12-31 $2.39B
Q3'24 2024-09-30 $1.39B
Q2'24 2024-06-30 $1.44B
Q1'24 2024-03-31 $1.75B
Q4'23 2023-12-31 $1.64B
Q3'23 2023-09-30 $1.28B
Q2'23 2023-06-30 $1.07B
Q1'23 2023-03-31 $1.05B
Q4'22 2022-12-31 $1.33B
Q3'22 2022-09-30 $1.04B
Q2'22 2022-06-30 $1.35B
Q1'22 2022-03-31 $1.36B
Q4'21 2021-12-31 $1.20B
Q3'21 2021-09-30 $1.09B
Q2'21 2021-06-30 $1.28B
Q1'21 2021-03-31 $1.09B
Q4'20 2020-12-31 $783.6M
Q3'20 2020-09-30 $967.8M
Q2'20 2020-06-30 $1.13B
Q1'20 2020-03-31 $1.35B
Q4'19 2019-12-31 $2.07B
Q3'19 2019-09-30 $2.06B
Q2'19 2019-06-30 $2.48B
Q1'19 2019-03-31 $2.31B
Q4'18 2018-12-31 $2.12B
Q3'18 2018-09-30 $2.89B
Q2'18 2018-06-30 $2.83B
Q1'18 2018-03-31 $2.31B
Q4'17 2017-12-31 $2.66B
Q3'17 2017-09-30 $3.17B
Q2'17 2017-06-30 $3.27B
Q1'17 2017-03-31 $3.72B
Q4'16 2016-12-31 $2.88B
Q3'16 2016-09-30 $1.63B
Q2'16 2016-06-30 $4.13B
Q1'16 2016-03-31 $3.77B
Q4'15 2015-12-31 $3.11B
Q3'15 2015-09-30 $3.48B
Q2'15 2015-06-30 $3.90B
Q1'15 2015-03-31 $4.71B
Q4'14 2014-12-31 $4.24B
Q3'14 2014-09-30 $4.00B
Q2'14 2014-06-30 $3.82B
Q1'14 2014-03-31 $3.64B
Q4'13 2013-12-31 $3.72B
Q3'13 2013-09-30 $4.00B
Q2'13 2013-06-30 $3.91B
Q1'13 2013-03-31 $3.95B
Q4'12 2012-12-31 $3.55B
Q3'12 2012-09-30 $3.35B
Q2'12 2012-06-30 $2.94B
Q1'12 2012-03-31 $2.73B
Q4'11 2011-12-31 $2.03B
Q3'11 2011-09-30 $2.26B
Q2'11 2011-06-30 $2.32B
Q1'11 2011-03-31 $2.64B
Q4'10 2010-12-31 $2.75B
Q3'10 2010-09-30 $2.72B
Q2'10 2010-06-30 $2.14B
Q1'11 2010-03-31
Q4'10 2009-12-31 $2.85B
Q3'10 2009-09-30
Q2'10 2009-06-30

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (CXW CIK 0001070985), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

ORIC

ORIC PHARMACEUTICALS, INC.

ABEO

ABEONA THERAPEUTICS INC.

FCUV

FOCUS UNIVERSAL INC.